The company is carrying out a trial pitched at obtaining US Food and Drug Administration (FDA) approval for AFL, as well as a ...

Such techniques can be automatically applied using implantable cardioverter defibrillators (ICDs) and offer the potential for painless termination of ventricular tachycardia (VT). Reduction in ...

ICDs may also misclassify shocks as ineffective if the post-shock rhythm is SVT in the VT rate zone (catecholamine-induced sinus tachycardia or shock-induced atrial fibrillation). Solutions ...

1The Adagio Medical, Inc. VT Cryoablation System (Catheter and Console) is indicated for the treatment of monomorphic ventricular tachycardia by ablation of arrhythmogenic tissues that drive and ...

FULCRUM-VT (Feasibility of Ultra-Low Temperature Cryoablation in Recurring Monomorphic Ventricular Tachycardia, NCT05675865) is a prospective, multi-center, open-label, single-arm study ...

(Nasdaq: ADGM; "Adagio Medical", "Adagio" or the "Company"), a leading innovator in catheter ablation technologies, today announced the completion of the first procedures in FULCRUM-VT U.S. Food ...

p =0.066], and ventricular tachycardia (VT) [cIRR 1.019, 95% CI 0.993-1.046, p=0.161]. For falsification testing, there was no change in hospitalizations for urinary stones [cIRR 1.006, 95% CI 0.986-1 ...

Ventricular tachycardia (VT), which causes the heart to beat abnormally fast, is a potentially life-threatening condition that can occur after a heart attack or in combination with other forms of ...

Holdings announced the completion of the first procedures in FULCRUM-VT U.S. Food and Drug Administration FDA Pivotal ...

Ventricular tachycardia (VT), which causes the heart to beat abnormally fast, is a potentially life-threatening condition that can occur after a heart attack or in combination with other forms of ...